Human Monoclonal Antibody Cocktail for the Treatment or Prophylaxis of Middle East Respiratory Syndrome Coronavirus.
The Journal of infectious diseases(2022)
摘要
REGN3048 and REGN3051 in combination were well tolerated. The clinical and preclinical data support further development for the treatment or prophylaxis of MERS-CoV infection.
更多查看译文
关键词
MERS,animal efficacy,first-in-human study,immunogenicity,monoclonal antibodies,pharmacokinetics,safety,tolerability
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要